NORWALK, CT -- Dec. 10, 2013 -- GE Capital, Corporate Retail Finance today announced it is serving as administrative and collateral agent on a $585 million senior secured credit facility for RadioShack Corporation (NYSE: RSH), a leading electronics retailer. The facility was provided alongside an additional $250 million secured term loan facility arranged by Salus Capital Partners, LLC.
business unit
tags
Solutions will help more than 12,000 health care professionals attest for Meaningful Use
BARRINGTON, IL: December 9, 2013 --- GE Healthcare today announced that Centricity Practice Solution 12.0 and Centricity EMR 9.8 have been certified as solutions that eligible healthcare professionals can use to attest for the Meaningful Use 2014 measures.
business unit
tags
Partnership formed by Nunatsiavut Group, Tasiujatsoak Trust and CAPE Fund
MONTREAL (QC) --- GE Capital today announced that it is providing a $10 million senior credit facility to a group of investors to purchase and operate Universal Helicopters Newfoundland and Labrador ("UHNL"), a regional helicopter services company. The new owners, through a limited partnership formed by Nunatsiavut Group of Companies, Tasiujatsoak Trust and CAPE Fund LP, are acquiring UNHL from its majority shareholder, Harry R. Steele, and minority shareholder, Norman Noseworthy.
business unit
tags
GE Capital rolling out enhanced digital tools to address site selection issues
SCOTTSDALE, AZ --- Restaurant franchise owners looking to grow their portfolios say that obtaining quality data is their biggest problem when looking for new sites, according to a recent survey by GE Capital, Franchise Finance (GEFF), a leading provider of financing to restaurant owners.
business unit
tags
Analysis of Multiplexed Proteins at Single-Cell Level Provides a Deeper Understanding of Cancer
ALISO VIEJO, CA, December 9, 2013 -- GE Healthcare today announced results from two studies that show how using the MultiOmyx™ Hodgkin Lymphoma (HL) Profile and an investigational profile for breast cancer may improve assessment of the two diseases in subsets of patients.